Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Tumor Necrosis Factor (TNF) Inhibitor Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tumor Necrosis Factor (TNF) Inhibitor Drugsmarket, defines the market attractiveness level of Tumor Necrosis Factor (TNF) Inhibitor Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tumor Necrosis Factor (TNF) Inhibitor Drugs industry, describes the types of Tumor Necrosis Factor (TNF) Inhibitor Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tumor Necrosis Factor (TNF) Inhibitor Drugs market and the development prospects and opportunities of Tumor Necrosis Factor (TNF) Inhibitor Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tumor Necrosis Factor (TNF) Inhibitor Drugs market in Chapter 13.
By Player:
Merck & Co Inc
Amgen Inc
UCB SA
AbbVie Inc
Novartis International AG
Johnson & Johnson Services Inc
Pfizer Inc
By Type:
Humira
Enbrel
Remicade
Simponi/Simponi Aria
Cimzia
Biosimilars
By End-User:
Rheumatoid Arthritis
Psoriasis
Psoriatic Arthritis
Crohn’s Disease
Ulcerative Colitis
Ankylosing Spondylitis
Juvenile Idiopathic Arthritis
Hidradenitis Suppurativa
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Analysis and Outlook to 2022
-
7.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption (2017-2022)
-
7.2 United States Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption (2017-2022)
-
7.3 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption (2017-2022)
-
7.4 China Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption (2017-2022)
-
7.5 Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption (2017-2022)
-
7.6 India Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption (2017-2022)
-
7.7 South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption (2017-2022)
8 Region and Country-wise Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Analysis and Outlook to 2028
-
8.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast (2022-2028)
-
8.2 United States Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast (2022-2028)
-
8.4 China Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast (2022-2028)
-
8.6 India Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast (2022-2028)
9 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Humira Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Enbrel Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Remicade Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Simponi/Simponi Aria Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Cimzia Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Biosimilars Consumption and Growth Rate (2017-2022)
-
9.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Psoriasis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Crohn’s Disease Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Ankylosing Spondylitis Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Juvenile Idiopathic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Hidradenitis Suppurativa Consumption and Growth Rate (2017-2022)
-
9.2.9 Global Others Consumption and Growth Rate (2017-2022)
10 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Simponi/Simponi Aria Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Cimzia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Crohn’s Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Ankylosing Spondylitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Juvenile Idiopathic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Hidradenitis Suppurativa Consumption Forecast and Growth Rate (2022-2028)
-
10.2.9 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Competitive Analysis
-
14.1 Merck & Co Inc
-
14.1.1 Merck & Co Inc Company Details
-
14.1.2 Merck & Co Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck & Co Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
14.2 Amgen Inc
-
14.2.1 Amgen Inc Company Details
-
14.2.2 Amgen Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
14.3 UCB SA
-
14.3.1 UCB SA Company Details
-
14.3.2 UCB SA Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 UCB SA Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
14.4 AbbVie Inc
-
14.4.1 AbbVie Inc Company Details
-
14.4.2 AbbVie Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
14.5 Novartis International AG
-
14.5.1 Novartis International AG Company Details
-
14.5.2 Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
14.6 Johnson & Johnson Services Inc
-
14.6.1 Johnson & Johnson Services Inc Company Details
-
14.6.2 Johnson & Johnson Services Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Services Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
14.7 Pfizer Inc
-
14.7.1 Pfizer Inc Company Details
-
14.7.2 Pfizer Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tumor Necrosis Factor (TNF) Inhibitor Drugs
-
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Picture
-
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption by Country (2017-2022)
-
Figure United States Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Humira Consumption and Growth Rate (2017-2022)
-
Figure Global Enbrel Consumption and Growth Rate (2017-2022)
-
Figure Global Remicade Consumption and Growth Rate (2017-2022)
-
Figure Global Simponi/Simponi Aria Consumption and Growth Rate (2017-2022)
-
Figure Global Cimzia Consumption and Growth Rate (2017-2022)
-
Figure Global Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Crohn’s Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
Figure Global Ankylosing Spondylitis Consumption and Growth Rate (2017-2022)
-
Figure Global Juvenile Idiopathic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Hidradenitis Suppurativa Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Simponi/Simponi Aria Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cimzia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crohn’s Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ankylosing Spondylitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Juvenile Idiopathic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hidradenitis Suppurativa Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
Table UCB SA (Foundation Year, Company Profile and etc.)
-
Table UCB SA Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB SA Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
Table Novartis International AG (Foundation Year, Company Profile and etc.)
-
Table Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
Table Johnson & Johnson Services Inc (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Services Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Services Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Service
-
